BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3106106)

  • 1. The outcome of continued treatment of luteinizing hormone-surged cycles in in vitro fertilization with the use of human menopausal gonadotropin.
    Huang KE; Chang SY; Muechler EK; Graham MC
    Fertil Steril; 1987 May; 47(5):816-20. PubMed ID: 3106106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro fertilization: diurnal and seasonal variation in luteinizing hormone surge onset and pregnancy rates.
    Casper RF; Erskine HJ; Armstrong DT; Brown SE; Daniel SA; Graves GR; Yuzpe AA
    Fertil Steril; 1988 Apr; 49(4):644-8. PubMed ID: 3127247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of exogenous human chorionic gonadotropin cycles with spontaneous luteinizing hormone surges on the outcome of in vitro fertilization.
    Wang TA; Armant DR; Taymor ML; Seibel MM
    Fertil Steril; 1987 Oct; 48(4):613-6. PubMed ID: 3115837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioactivity of endogenous luteinizing hormone during superovulation therapy for in vitro fertilization in normal-cycling women.
    Abuzeid MI; Hodges JK; Harlow CR; Hull MG
    J Assist Reprod Genet; 1996 Sep; 13(8):629-34. PubMed ID: 8897122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women.
    Ferraretti AP; Garcia JE; Acosta AA; Jones GS
    Fertil Steril; 1983 Dec; 40(6):742-7. PubMed ID: 6418573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and influence of an endogenous serum luteinizing hormone surge after ovulation induction in stimulated cycles.
    Kainz C; Reinthaller A; Schneider B; Fischl F; Bieglmayer C
    Gynecol Endocrinol; 1994 Dec; 8(4):227-32. PubMed ID: 7709761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.
    Kreiner D; Droesch K; Itskovitz J; Liu HC; Navot D; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):265-7. PubMed ID: 3148022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intermittent and continuous use of a gonadotropin-releasing hormone antagonist (Nal-Glu) in in vitro fertilization cycles: a preliminary report.
    Cassidenti DL; Sauer MV; Paulson RJ; Ditkoff EC; Rivier J; Yen SS; Lobo RA
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 1):1806-10. PubMed ID: 1750479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration.
    Lejeune B; Degueldre M; Camus M; Vekemans M; Opsomer L; Leroy F
    Fertil Steril; 1986 Mar; 45(3):377-83. PubMed ID: 3949037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with and without gonadotropin surges during follicular recruitment in an in vitro fertilization/embryo transfer program.
    Nader S; Berkowitz AS; Maklad N; Wolf DP; Held B
    Fertil Steril; 1986 Jan; 45(1):75-8. PubMed ID: 3080347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.
    Droesch K; Muasher SJ; Kreiner D; Jones GS; Acosta AA; Rosenwaks Z
    Fertil Steril; 1988 Sep; 50(3):451-6. PubMed ID: 3137100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro fertilization: determination of follicular maturation for timing of human chorionic gonadotropin administration.
    Casper RF; Armstrong DT; Brown SE; Daniel SA; Yuzpe AA; Erskine H
    Fertil Steril; 1987 Feb; 47(2):345-9. PubMed ID: 3102289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects with regard to the occurrence of an endogenous luteinizing hormone surge in gonadotropin-induced normal menstrual cycles.
    Van Uem JF; Garcia JE; Liu HC; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1986 Dec; 3(6):345-9. PubMed ID: 2949033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary luteinizing hormone surge and outcome of in vitro fertilization and embryo transfer].
    Wu Y; Zhang LZ; Lu P
    Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):74-7, 122. PubMed ID: 8033629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted LH surge after HCG administration in cycles superovulated for in-vitro fertilization.
    Hamori M; Stuckensen JA; Rumpf D; Kniewald T; Kniewald A; Marquez M
    Hum Reprod; 1989 May; 4(4):392-5. PubMed ID: 2501335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
    Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
    Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of estradiol response in patients with endogenous gonadotropin surges during follicular recruitment in an in vitro fertilization and embryo transfer program.
    Nader S; Berkowitz AS; Ochs D; Wolf DP; Maklad N; Held B
    Fertil Steril; 1986 Sep; 46(3):448-51. PubMed ID: 3091410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of short pituitary suppression with gonadotropin-releasing hormone agonist leuprolide during induction of ovulation for in vitro fertilization.
    Henig I; Chan PJ; Prough SG; Tredway DR
    J In Vitro Fert Embryo Transf; 1989 Aug; 6(4):195-200. PubMed ID: 2515234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Sep; 108(3):505-512.e2. PubMed ID: 28697910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.